Gubra A/S

Gubra A/S

GUBRA.CO

Get informed when a big investor buys or sells

+ Follow
Market Cap$4.65B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Gubra A/SGubra A/S-25.4-150%1.70.2

Share Statistics

Market cap$4.65 Billion
Enterprise Value$4.82 Billion
Dividend Yield$- (-)
Earnings per Share$103.83
Beta0.31
Outstanding Shares16,412,388

Return

Return on Equity149.59%ROE
Return on Assets120.87%
Return on Invested Capital167.83%

Valuation & Multiples

P/E Ratio-25.43P/E Ratio
PEG23.93PEG
Price to Sales1.67Price to Sales
Price to Book Ratio4.69Price to Book Ratio
Enterprise Value to Revenue1.66
Enterprise Value to EBIT2.38
Enterprise Value to Net Income3
Total Debt to Enterprise0.04
Debt to Equity0.19Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
August 20, 2026
EPS Estimate
$-5.01
Average shareholder expectation
Revenue Estimate
$131.39 M
Average shareholder expectation

Next Earnings Call

Expected Date
March 3, 2027
EPS Estimate
$-5.57
Average shareholder expectation
Revenue Estimate
$212.21 M
Average shareholder expectation

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

ESG Score

No data

About Gubra A/S

330 employees
CEO: Markus Rohrwild

Gubra A/S is a biotechnology firm engaged in two core activities: offering contract research organization (CRO) services for pre-clinical development, and advancing its own internal early-stage drug and target discovery initiatives. Its ...